Mark Angelino

Mark Angelino

Direktor/Vorstandsmitglied bei Arbor Biotechnologies, Inc.

51 Jahre
Health Technology
Finance
Commercial Services

Profil

Mark joined TRV as a venture partner in 2021.
He most recently served as Chief Operating Officer at Generation Bio (a non-viral, genetics medicine company), which he co-founded in 2016.
From 2012 to 2016, Mark was on the leadership team at bluebird bio, as senior vice president of pharmaceutical sciences and rare disease franchise head.
These two experiences combining novel therapeutic approaches and early builds is what drew Mark to Third Rock and its patient-centric mission.
Prior to that, at companies like Baxter Healthcare, Archemix, Millennium and DuPont Pharma, Mark acquired broad operational experience that cut across multiple modalities (small-molecules, ADCs, biologics, peptides, oligonucleotides, complex mixtures, and gene therapies), as well as across various stages of therapeutic development- from early translation to product launches.
He also currently serves on the Board of Directors of Arbor Biotechnologies.

Aktive Positionen von Mark Angelino

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 03.03.2021
Private Equity Investor 01.03.2021
Alle aktiven Positionen von Mark Angelino

Ehemalige bekannte Positionen von Mark Angelino

UnternehmenPositionEnde
GENERATION BIO CO. Gründer 01.02.2021
BLUEBIRD BIO, INC. Corporate Officer/Principal 01.10.2016
Private Equity Investor 01.05.2012
Corporate Officer/Principal 01.12.2010
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Mark Angelino im Detail an

Ausbildung von Mark Angelino

Massachusetts Institute of Technology Doctorate Degree
The Cooper Union for the Advancement of Science & Art Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mark Angelino im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

GENERATION BIO CO.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

Private Unternehmen7

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Producer Manufacturing

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Mark Angelino